AzTrials
AzTrials

HIV-related StigmaNCT06724445

Empathy in Frames: Animated Cartoons To Reduce HIV Stigma Among South African Young Adults

A study testing Thabo cartoon and Steve cartoon in people with HIV-related Stigma, run by Columbia University at 1 site in South Africa.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study looks at whether using cartoons that reflect the culture of South Africa can help change how young adults there think about HIV/AIDS. This study will test two types of cartoons in a two-arm (treatment, comparator) randomized controlled trial design-one with Black characters and one with White characters-to… Read more about this study

Who is it for?
Ages 18 to 35 years
Conditions the study is for
HIV-related Stigma
What is being tested?
Thabo cartoon and Steve cartoon
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,496 participants
Where
1 siteSouth Africa
Study dates
11 Nov 2024to 23 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Must self-identify as Black South African
  • Must be HIV seronegative
  • Age range: 18-35 years
  • Must currently reside in South Africa
  • Must have basic English language comprehension
  • Must have internet access to view video content

Who cannot join

  • Prior participation in HIV stigma reduction interventions
  • HIV seropositive status
  • Non-Black South African identity
  • Outside target age range (18-35)

Trial locations and contacts

1 site in 1 country.

South Africa1 site
  • Busara Center for Behavioral Economics

    Multiple Locations

Other trials in South Africa

About this study

Official title: Empathy in Frames: Assessing the Impact of Ethnic Concordance in Animated Cartoons on HIV/AIDS Stigma Among South African Young Adults

This study looks at whether using cartoons that reflect the culture of South Africa can help change how young adults there think about HIV/AIDS. This study will test two types of cartoons in a two-arm (treatment, comparator) randomized controlled trial design-one with Black characters and one with White characters-to see how they affect people's attitudes and knowledge about HIV/AIDS. Randomly allocated participants will be Black seronegative South African adults between 18 and 35 years old. This group was chosen because they're a demographic disproportionately affected by HIV, they're at a high point in their lives for shaping and sharing beliefs, and they're also highly active online, which is where this study takes place.

The cartoons will show the daily struggles of the protagonist living with HIV/AIDS, and end with a call to action. The study aims to highlight how the characters' ethnicity influences how viewers feel about and remember the message. The investigators want to understand if seeing characters who look like them helps people understand and empathize more. The aim of this study is to learn how cultural representation can improve health communication and guide future efforts to reduce stigma in different communities. Ultimately, the investigators hope this study will contribute to better public health messages and create a more accepting environment for people with HIV/AIDS.

Being tested
Thabo cartoon, Steve cartoon

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Thabo cartoonBehavioural

    The animated cartoon features Thabo, a Black South African man living with HIV. Through his narrative, viewers follow his daily experiences managing his condition and confronting societal stigma in a South African context. The story explores his interactions with family, friends, and community members, highlighting both challenges and moments of resilience. The animation concludes with Thabo delivering an anti-stigma message directly to viewers.

  • Steve cartoonBehavioural

    The animated cartoon follows Steve, a White man living with HIV. His narrative parallels Thabo's, showing his daily experiences managing HIV and facing societal stigma. The story depicts his interactions with family, friends, and community members, presenting the same situations and challenges as in Thabo's story. The animation ends with Steve delivering the same anti-stigma message to viewers.

Study groups in NCT06724445
Study groupRoleWhat they receive
Thabo groupExperimentalParticipants will view a cartoon video featuring a Black seropositive protagonist
Receives: Behavioral: Thabo cartoon
Steve groupActive comparatorParticipants will view a cartoon video featuring a White seropositive protagonist
Receives: Behavioral: Steve cartoon

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Attitudes towards HIV

    HIV-related attitudes are measured using Beaulieu et al's SAT-PLWHA-S survey instrument, designed specifically to measure stigmatizing attitudes towards HIV/AIDS. The objective of this questionnaire is to measure participants' own HIV-related behaviors. This measurement uses a 5-point Likert-type scale (from 1 =strongly disagree to 5 = strongly agree) to understand how participants behave when confronted with HIV-related information. Respondents will be asked to answer items such as "Stories featuring diverse ethnic backgrounds make me feel more connected to the content" or "Ethnic diversity in health messages affects my trust in their accuracy".

    A higher score indicates more positive attitudes and comfort levels regarding HIV and people living with HIV.

    Measured: Up to 14 days

  2. Health Ethnicity Perceptions

    A composite index measuring participants' perceptions of the relevance, relatability, and trustworthiness of health messages based on the ethnicity of the message source. Items assess how protagonist ethnicity influenced viewers' ability to engage with the content, trust the information, and find the message relatable.

    3-item Likert scale index (1-5), with higher scores indicating more positive perceptions of ethnic concordance in health messaging.

    Measured: Up to 14 days

Secondary outcomes (3)
  1. Behavioral intentions

    Behavioral Intentions will be measured using a shortened version of the Theory of Planned Behavior (TPB) Questionnaire used to assess attitudes toward the behavior, subjective norms, and perceived behavioral control. Focusing on attitudes, subjective norms, perceived behavioral control, and intention towards a specific behavior (e.g., engaging in HIV prevention practices) can yield a concise measure. This measure uses a 5 point Likert-type scale (from 1 = strongly disagree to 5 = strongly agree).

    A higher score indicates greater readiness and confidence to engage in HIV stigma reduction activities.

    Measured: Up to 14 days

  2. HIV knowledge

    HIV knowledge is assessed using a shortened version of Carey and Colls' HIV Knowledge Questionnaire (HIV-KQ-18). Respondents will be required to rate their understanding of the infection, transmission, and treatment of HIV on a binary scale (1 = true, 2 = false). Typical questions range from "Can HIV be transmitted by sharing food with someone who is HIV positive?" to "A person with HIV can have an undetectable viral load with proper treatment".

    A higher score indicates greater certainty of HIV knowledge.

    Measured: Up to 14 days

  3. Viewer Engagement with Cartoon

    Quality of engagement will be measured using a shortened version of the User Engagement Scale (UES) adapted for health-related animated cartoons. This scale is designed to provide insights into how these interventions capture and hold the audience's attention, and potentially influence their health knowledge and behaviors. This measurement uses a 5-point Likert-type scale (from 1 = strongly disagree to 5 = strongly agree) to measure focused attention, perceived usability, aesthetic appeal, reward, and endurability.

    A higher score indicates greater perceived effectiveness and engagement with cartoon-based HIV health messaging.

    Measured: 14 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Dec 2024
  2. Study start11 Nov 2024
  3. Primary completion23 Dec 2024
  4. Study completion23 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
1,496 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06724445
Sponsor's protocol ID
AAAU5702
Status last verified
Apr 2025
First submitted
5 Dec 2024
Last updated
20 Apr 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Thabo cartoon and Steve cartoon in people with HIV-related Stigma, run by Columbia University at 1 site in South Africa.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Africa. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Attitudes towards HIV (time frame: Up to 14 days). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in